Tue, Jul 22, 2014, 8:21 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Cytomedix, Inc. Message Board

  • hwmccusker hwmccusker Mar 4, 2013 10:48 AM Flag

    CMS Approval

    With these protocol approvals, clinicians can use AutoloGel(TM) to treat Medicare beneficiaries with chronic wounds and receive reimbursement for the product under the Coverage with Evidence Development (CED) program. CMXI expects to begin rolling out the protocols to wound care clinics during March, and anticipates the first patients will be treated under the protocols soon. CMXI closed at $0.50 on 3/1/13. Ranked a “BUY” as it appears Osiris’ Grafix also targets diabetic ulcers, it appears to have direct overlap with CMXI ‘s AutoloGel . However, under the approved protocols, CMXI … expects to treat more than 1,200 patients with AutoloGel in outpatient wound care centers affiliated with Intellicure and the US Wound Registry while OSIR has to develop a sales and marketing group to advance.

    Sentiment: Buy

 
CMXI
0.40-0.01(-1.72%)Jul 22 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.